Lack of adherence with preoperative B-blocker recommendations in a multicenter study

  • Debra Quinn Kolodner
  • Huong Do
  • Mary Cooper
  • Eliot Lazar
  • Mark Callahan
Original Articles


BACKGROUND: Clinical guidelines support the use of preoperative B-blocker in select patients. Patient safety groups have sought to measure the level of adherence to these recommendations.

OBJECTIVE: This study was performed to compare the utilization of preoperative B-blocker with current guidelines across multiple diverse institutions.

DESIGN: Retrospective chart review was performed of inpatients undergoing noncardiac surgery across 5 hospital centers during 2003 to 2004. The primary outcome of interest was the administration of preoperative B-blocker.

PARTICIPANTS: The study sample included 1,304 randomly selected patients meeting the guideline criteria for preoperative B-blockade.

MEASUREMENTS AND MAIN RESULTS: Among patients meeting recommendations for preoperative B-blocker, only 44% (430/983) received B-blocker before surgery. Patients who had not previously received B-blocker were given B-blocker before surgery in only 14% (85/600) of cases. Target heart rates goals for perioperative B-blockade were achieved in 26% (113/430) of cases. Predictors for initiating preoperative B-blocker included nonelective surgery or a history of hypertension or diabetes. Individual hospitals were independently predictive of preoperative B-blocker administration in multivariable models.

CONCLUSIONS: Preoperative B-blocker was significantly underutilized when compared with the current guideline recommendations. Target heart rate goals were not achieved in clinical practice, and few hospitalized patients had preoperative B-blockade initiated. The lack of adherence to preoperative B-blocker recommendations in practice may be impacted by ongoing clinical questions regarding the appropriate selection of candidates for this therapy. Further efforts toward achieving guideline recommendations for preoperative B-blocker use should be focused on the subset of patients that are uniformly agreed upon to be at high risk for cardiac events.

Key words

adrenergic β-antagonists perioperative care quality indicators health care practice guidelines 


  1. 1.
    Auerbach A, Goldman L. B-blockers and reduction of cardiac events in noncardiac surgery. JAMA. 2002;287:1445–7.CrossRefPubMedGoogle Scholar
  2. 2.
    Eagle KA, Berger PB, Calkins H, et al. ACC/AHA Guideline Update on Perioperative Cardiovascular Evaluation for Noncardiac Surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [American College of Cardiology Web site]. Available at: Accessed verified December 21, 2005.Google Scholar
  3. 3.
    American College of Physicians. Guidelines for assessing and managing the perioperative risk from coronary artery disease associated with major noncardiac surgery. Ann Intern Med. 1997;127:313–28.Google Scholar
  4. 4.
    Boersma E, Poldermans D, Bax J, et al. Predictors of cardiac events after major vascular surgery. JAMA. 2001;285:1865–73.CrossRefPubMedGoogle Scholar
  5. 5.
    Redelmeier D, Scales D, Kopp A. Beta blockers for elective surgery in elderly patients; population based, retrospective cohort study. BMJ. 2005;331:932.CrossRefPubMedGoogle Scholar
  6. 6.
    Mangano D, Layug E, Wallace A, et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med. 1996;335:1713–20.CrossRefPubMedGoogle Scholar
  7. 7.
    Poldermans D, Boersam E, Bax J, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery: Dutch echocardiographic cardiac risk evaluation applying stress echocardiography study group. N Engl J Med. 1999;341:1789–94.CrossRefPubMedGoogle Scholar
  8. 8.
    B-blocker Heart Attack Study Group. The B-blocker heart attack trial. JAMA. 1981;246:2073–4.CrossRefGoogle Scholar
  9. 9.
    The Norwegian Multi-Center Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med. 1981;204:801–7.Google Scholar
  10. 10.
    Agency for Healthcare Research and Quality. Making Health Care Safer: A Critical Analysis of Patient Safety Practices. Rockville, MD. July 2001. AHRQ Publication No. 01-E057. Available at: Accessed December 21, 2005.Google Scholar
  11. 11.
    The Leapfrog Group. (2004). Available at: Accessed December 21, 2005.Google Scholar
  12. 12.
    Safe practices for better healthcare: a consensus report. National Quality Forum, Washington, DC, 2003. (Publication no. NQFCR-05-03).Google Scholar
  13. 13.
    Siddiqui AK, Ahmed S, Delbeau H, Conner D, Mattana J. Lack of physician concordance with guidelines on the perioperative use of B-blockers. Arch Intern Med. 2004;164:664–7.CrossRefPubMedGoogle Scholar
  14. 14.
    Lindenauer PK, Fitzgerald J, Hoople N, Benjamin EM. The potential preventability of postoperative myocardial infarction: underuse of perioperative beta-adrenergic blockade. Arch Intern Med. 2004;164:762–6.CrossRefPubMedGoogle Scholar
  15. 15.
    Lindenauer PK, Pekow P, Wang K, et al. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med. 2005;353:349–61.CrossRefPubMedGoogle Scholar
  16. 16.
    Butler J, Arbogast PG, BeLue R, et al. Outpatient adherence to beta-blocker therapy after acute myocardial infarction. J Am Coll Cardiol. 2002;40:1589–95.CrossRefPubMedGoogle Scholar
  17. 17.
    Krumholz HM, Chen J, Rathore SS, Wang Y, Radford MJ. Regional variation in the treatment and outcomes of myocardial infarction: investigating New England’s advantage [see comment]. Am Heart J. 2003;146:242–9.CrossRefPubMedGoogle Scholar
  18. 18.
    Eagle KA, Lee TH, Brennan TA, Krumholz HM, Weingarten S. Practice guidelines and the quality of care: task force 2 guideline implementation. J Am Coll Cardiol. 1997;29:1125–79.Google Scholar
  19. 19.
    Pollard JB, Chow RC, Hansen JR. Effectiveness of preprinted order forms in promoting perioperative B-blocker use. Am J Health-Syst Pharm. 2002;59:359–60.PubMedGoogle Scholar
  20. 20.
    Howell SJ, Sear JW, Foex P. Peri-operative B-blockade: a useful treatment that should be greeted with cautious enthusiasm. Br J Anaesth. 2001;86:161–3.CrossRefPubMedGoogle Scholar
  21. 21.
    Auerbach AD, Goldman L. beta-Blockers and reduction of cardiac events in noncardiac surgery: clinical applications. JAMA. 2002;287:1445–7.CrossRefPubMedGoogle Scholar
  22. 22.
    London MJ, Itani K, Perrino AC, et al. Perioperative beta-blockade: a survey of physician attitudes in the department of veterans affairs. J Cardiothoracic Vasc Anesth. 2004;18:14–24.CrossRefGoogle Scholar
  23. 23.
    VanDenKerkhof EG, Milne B, Parlow JL. Knowledge and practice regarding prophylactic perioperative beta blockade in patients undergoing noncardiac surgery: a survey of canadian anesthesiologists. Anesth Analg. 2003;96:1558–65.CrossRefPubMedGoogle Scholar
  24. 24.
    Juul AB, Wetterslev J, Kofoed-Enevoldsen A, Callesen T, Jensen G, Gluud C. The diabetic postoperative mortality and morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery. Am Heart J. 2004;147:677–83.CrossRefPubMedGoogle Scholar
  25. 25.
    Rock P. The future of anesthesiology is perioperative medicine. Anesthesiol Clin North Am. 2000;18:495–513.CrossRefGoogle Scholar
  26. 26.
    Zaugg M, Tagliente T, Lucchinetti E, et al. Beneficial effects from beta-adrenergic blockade in elderly patients undergoing non-cardiac surgery. Anesthesiology. 1999;91:1674–86.CrossRefPubMedGoogle Scholar
  27. 27.
    London MJ, Zaugg M, Schaub MC, Spahn DR. Perioperative B-adrenergic receptor blockade. Anesthesiology. 2004;100:170–5.CrossRefPubMedGoogle Scholar
  28. 28.
    Devereaux PJ, Yusuf S, Yang H, Choi PT-L, Guyatt GH. Are the recommendations to use perioperative {beta}-blocker therapy in patients undergoing noncardiac surgery based on reliable evidence? Can Med Assoc J. 2004;171:245–7.CrossRefGoogle Scholar

Copyright information

© Society of General Internal Medicine 2006

Authors and Affiliations

  • Debra Quinn Kolodner
    • 1
    • 3
  • Huong Do
    • 2
  • Mary Cooper
    • 3
  • Eliot Lazar
    • 4
  • Mark Callahan
    • 2
    • 3
  1. 1.Division of Outcomes and Effectiveness Research, Department of MedicineColumbia University College of Physicians & Surgeons, Weill Medical College of CornellNew YorkUSA
  2. 2.Division of Outcomes and Effectiveness Research, Department of Public HealthWeill Medical College of CornellNew YorkUSA
  3. 3.New York-Presbyterian HospitalNew YorkUSA
  4. 4.New York-Presbyterian HospitalWeill Medical College of CornellNew YorkUSA

Personalised recommendations